Ranjini K Sundaram Selected Research

Ranjini K Sundaram Research Topics

Disease

16	Neoplasms (Cancer) 05/2024 - 02/2015
7	Glioma (Gliomas) 01/2022 - 02/2015
5	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2022 - 01/2019
4	Glioblastoma (Glioblastoma Multiforme) 01/2022 - 01/2017
3	Alzheimer Disease (Alzheimer's Disease) 01/2014 - 02/2008
1	Intellectual Disability (Idiocy) 09/2021
1	alpha-Thalassemia 09/2021
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 06/2021
1	Cardiotoxicity 04/2021
1	Paraganglioma (Paragangliomas) 01/2018
1	Pheochromocytoma 01/2018
1	Hereditary Neoplastic Syndromes (Cancer Syndrome, Hereditary) 01/2018
1	Hereditary leiomyomatosis and renal cell cancer 01/2018
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Hypersensitivity (Allergy) 08/2017
1	Pathologic Processes 01/2017
1	Hypoxia (Hypoxemia) 01/2017
1	Diffuse Intrinsic Pontine Glioma 01/2017
1	Disease Progression 01/2017
1	Cardiac Arrhythmias (Arrythmia) 03/2016
1	Heart Failure 03/2016
1	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2012
1	Memory Disorders (Memory Loss) 02/2008
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 08/2002
1	Papilloma (Papillomatosis) 08/2002
1	Papillomavirus Infections 08/2002

Drug/Important Bio-Agent (IBA)

6	Peptides (Polypeptides)IBA 01/2022 - 02/2008
5	Poly(ADP-ribose) Polymerase InhibitorsIBA 09/2021 - 01/2017
5	DNA (Deoxyribonucleic Acid)IBA 06/2021 - 02/2015
4	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 09/2021 - 01/2017
3	EnzymesIBA 05/2024 - 01/2018
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2019
3	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 08/2017 - 02/2015
2	exatecan (DX 8951f)IBA 01/2022 - 06/2021
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2022
2	Topoisomerase InhibitorsIBA 12/2021 - 06/2021
2	AntigensIBA 12/2021 - 06/2021
2	MibefradilIBA 04/2021 - 02/2015
2	dipinacoline glutamateIBA 01/2019 - 01/2017
2	Amyloid (Amyloid Fibrils)IBA 06/2012 - 02/2008
1	N- (6- chlorophenoxyhexyl)- N''- cyano- N''- 4- pyridylguanidine (CHS 828)IBA 05/2024
1	TransferasesIBA 01/2022
1	Liposomes (Liposome)IBA 01/2022
1	O-(6)-methylguanineIBA 01/2022
1	ceralasertibIBA 01/2022
1	Immunoconjugates (Immunoconjugate)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 01/2022
1	CamptothecinIBA 01/2022
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2022
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Protein Kinase InhibitorsIBA 06/2021
1	isocitric acid (isocitrate)IBA 06/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 04/2021
1	A-Form DNA (A-DNA)IBA 01/2019
1	Checkpoint Kinase 1IBA 01/2019
1	Alkylating AgentsIBA 01/2019
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2019
1	NAD (NADH)IBA 01/2019
1	Nicotinamide PhosphoribosyltransferaseIBA 01/2019
1	Fumarate Hydratase (Fumarase)IBA 01/2018
1	4-dioxanoneIBA 01/2018
1	poly(omega- pentadecalactone- co- p- dioxanone)IBA 01/2018
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 01/2018
1	Succinic Acid (Succinate)IBA 01/2018
1	FumaratesIBA 01/2018
1	alpha-hydroxyglutarateIBA 01/2017
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2017
1	DioxygenasesIBA 01/2017
1	Cardiac GlycosidesIBA 03/2016
1	Heterocyclic Compounds (Compounds, Heterocyclic)IBA 01/2014
1	Therapeutic UsesIBA 06/2012
1	Amino Acids FDA Link 06/2012
1	UbiquitinIBA 08/2002
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2002
1	VaccinesIBA 08/2002

Therapy/Procedure

4	Therapeutics 09/2021 - 02/2015
3	Radiotherapy 04/2021 - 01/2017
1	Drug Therapy (Chemotherapy) 01/2017
1	Combined Modality Therapy 01/2017